Maraoui Claude's Form 4 filing
Journey Medical Corp (DERM) · filed Sep 8, 2023
- Accession no.
- 0001104659-23-099230
- Filed
- Sep 8, 2023
- Trade date
- Sep 6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $65.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maraoui ClaudeCIK 0001893880 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +26,044 | $2.52 | +$65,630.88 | 2,153,430 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.